
Earlier this month, the first-ever proposed cure for cancer was published in the ‘Cancer Research’ journal in the United Kingdom. Dr Lesley Walker, a PhD in Immunology, said in a press release that the new treatment, which works using the principles of genetics, was a breakthrough in the challenging oncology field and could soon be offered as a treatment method for human patients. Developed by Dr Andreas Schatzlein, of the School of Pharmacy in London, the treatment has just concluded its testing phases on mice subjects with heartening success. So how does it work?
For More Information -
Original Scientific Report for Trial:
“Cancer-Specific Transgene Expression Mediated by Systemic Injection of Nanoparticles” by Schatzlein et al. “Cancer Research” journal. 3rd March, 2009. doi:10.1158/0008-5472.CAN-08-2657
http://cancerres.aacrjournals.org/cgi/content/abstract/0008-5472.CAN-08-2657v1?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author2=Schatzlein&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
Press Release/News Article:
“Nano-Particles Loaded With Anti-Tumour Genes Zap Cancer Cells” by Catharine Paddock, PhD. Medical News Today. 11th March, 2009.
http://www.medicalnewstoday.com/articles/141924.php
Cancer Research UK: http://info.cancerresearchuk.org/news/archive/pressreleases/2009/march/nano-treatments-target-cancer
Image: www.biotech-weblog.com
By J. Tilling (21st March, 2009)